Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Net Asset Quality Index
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Net Asset Quality Index of -4.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.79 Million minus total liabilities of $2.92 Million yields net assets of $-132.60K. A higher index indicates a stronger, lower-leverage balance sheet. Read LIMN total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Liminatus Pharma, Inc. Class A Common Stock Net Asset Quality Index Over Time (2021–2025)
This chart shows how Liminatus Pharma, Inc. Class A Common Stock's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at -4.8%, representing net assets of $-132.60K against total assets of $2.79 Million USD. For live market cap and overall valuation, see market value of Liminatus Pharma, Inc. Class A Common St.
Annual Net Asset Quality Index for Liminatus Pharma, Inc. Class A Common Stock (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Liminatus Pharma, Inc. Class A Common St shareholders equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -1914.0% | $-9.81 Million | $512.79K | $10.33 Million | ▼ -1353.0 pp |
| 2024 | -561.0% | $-15.87 Million | $2.83 Million | $18.70 Million | ▼ -323.5 pp |
| 2023 | -237.5% | $-10.69 Million | $4.50 Million | $15.19 Million | ▼ -245.9 pp |
| 2022 | 8.4% | $1.29 Million | $15.49 Million | $14.19 Million | ▼ -83.8 pp |
| 2021 | 92.2% | $254.87 Million | $276.44 Million | $21.57 Million | — |